Obesity continues to increase in prevalence, now affecting more than o
ne third of the adult population of the United States. The health risk
s of obesity are proportional to increase in body mass index (weight i
n kilograms divided by the square of the height in meters), and includ
e adult-onset diabetes, hypertension, hyperlipidemia and coronary arte
ry disease, respiratory failure, and increased cancer risk. The recogn
ized gastrointestinal complications reviewed in this article include i
ncreased risks of gallstones (especially during weight reduction); pan
creatitis related to gallstones or hyperlipidemia with worse clinical
outcome; nonalcoholic steatohepatitis; and increased risks of adenocar
cinoma of the esophagus, colorectal adenoma, and cancer. New studies c
ontinue to define abnormalities in the genetic regulation of appetite
and energy metabolism in experimental animals and human obesity. Treat
ment options continue to evolve, with improved pharmacologic approache
s to appetite and strong support for gastric bypass surgery as the mos
t effective treatment of severely obese patients.